The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Was previously discussed on this bb.
https://seekingalpha.com/news/3593929-tlsa-falls-14-suggestions-spread-robinhood-traders-confused-tsla
Posts some 3-4 weeks ago alluded to the probabilty of mistaken identitity between Tiziana & Tesla which resulted in the very rapid rise. Could it be the same reasoning is behind the fall? Tesla has been the subject of significant shorting & their sp has taken a very big hit last 2 days. According to this link short interest in Tiziana is much reduced https://fintel.io/ss/us/tlsa
If we are part of this trial (which seems quite possible) would have thought it unlikely we'll get official news prior to the end date; more end September. We could get BAMS news very near future, & if it is as good as implied think the effect on the sp to be dramatic (infers, only, high s/s on the lft) due elevated expectations. Wonder if, as already discussed on this board, whether or not both devices are subject to NDAs, in which case news end September.
Lets hope we get something related to either soon, so the very tedious noise on here can be drowned out.
For those who think there is no 'shorting' in the sp, take a look at bottom of page: https://fintel.io/ss/us/tlsa
For me, breakout/breakdown 186/156. However, very much like avct, news driven, so unpredictable. For now seems comfortable in current zone, but news (or lack of it) will prove the driver.
150k @ 16:32
Not really surprising. Recent fund raisers (sng, odx,avct, gdr) all suffered similar fate. The sp has already delivered (nicely) for those who bought in below £1.50, & will recover (& beyond) to the heights recently achieved, it's just a matter of patience. Traders will have their moment as will those who hold for the mid/longer term.
Sure your correct, but not understand why you think a sole investor took the shares. Great for us if that the case.
If of any interest, according to CNN
https://money.cnn.com/quote/shareholders/shareholders.html?symb=TLSA&subView=institutional
Okyo is an embryonic tils, same management, structure, etc. Probably be a while for it to get to where we are, although probably one for the future. A long volatile journey ahead of it.
According to Investopedia
"The record date is the cut-off date used to determine which shareholders are entitled to a corporate dividend.
The record date will usually be the day following the ex-dividend date, which is the trading date on (and after) which the dividend is not owed to a new buyer of the stock.
To be eligible for the dividend, you must buy the stock at least two business days before the record date."
At moment showing as 18m+ against daily average 305k.
Even if US sp was $8.50, that wud equate to £3.20+. Onwards & upwards.
Think it just as well we're not keeping pace with US sp, cos it's got to be a spike. Traders will be very happy to jump on & off the train - some with big profits.
Think expectation been ramped up for some reason & I agree with comments/observations posted by Pigster & Timster earlier today. Can imagine the reaction from some contributors should avct not oblige.
When the (hoped for) outcome is communicated the problem faced will be supply to fill demand, as AS has alluded.
Not sure whether this already been covered. If our tech is being used for delivery & trial(s) succesful, surely an early 'earner', while substantiating the methodology. Any opinions?
https://www.clinicaltrialsarena.com/news/gilead-inhaled-remdesivir-phasei/
https://www.globenewswire.com/news-release/2020/06/29/2054456/0/en/Tiziana-Life-Sciences-Announces-Agreement-with-STC-Biologics-for-GMP-Manufacturing-of-an-anti-Interleukin-6-Receptor-Monoclonal